Overview

Update
Total Equity Funding
$126M in 4 Rounds from 7 Investors
Most Recent Funding
$70M Private Equity on May 14, 2013
Headquarters:
San Carlos, CA
Description:
Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.
Founders:
Categories:
Pharmaceutical, Therapeutics, Biotechnology
Website:
http://www.alvinepharma.com

Company Details

Update

Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.

Funding Rounds (6) - $138.01M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2013$70M / Private Equity1
Jan, 2013$6.01M / Debt Financing0
Oct, 2011$6.01M / Debt Financing0
Mar, 2011$26.5M / Venture0
Sep, 2009$21.5M / Series A6
Sep, 2006$8M / Series A2

Current Team (12)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • HQ

    75 Shoreway Rd.

    Suite B

    San Carlos, CA 94070

    USA

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos